About Carole Welsch
Carole Welsch is a chief operating officer, co-founder at Seraxis.
Carole Welsch first appears on SEC filings in 2021.
Experience
This experience comes from Carole Welsch's profile and from SEC filings. For roles taken from filings, the years are when the filings name Carole Welsch in the role, so the role may have started earlier or lasted longer.
Seraxis Holdings, Inc. Current
Chief Operating Officer, Co-Founder
2016 – Present · Germantown, MD
Develops cell replacement therapy for people with insulin-dependent diabetes.
NP
Novartis Pharmaceuticals
Medical Scientific Associate Director, Oncology/ Hematology (2014 – 2016)
Research Scientist (1998 – 2003)
1998 – 2016
QI
QIAGEN Inc
Associate Director, Marketing, Personalized Healthcare, Oncology & Hematology
2009 – 2014
VU
Vanda Pharmaceuticals Inc., Singapore and USA
New Product Planning Manager
2005 – 2009
NH
National Cancer Center, Singapore General Hospital
Research Scientist
2003 – 2004
Key Colleagues at Startups
The people Carole Welsch works with at each company, as listed on that company's latest Form D.
Seraxis Holdings, Inc. · Form D, Sep 24, 2026
Jerry Baty
Director
William Rust
Chief Executive Officer, Founder, Director of Board